Samoa Wellness Report
SEE OTHER BRANDS

Your health and wellness news reporter from Samoa

Samoa Wellness Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Samoa Wellness Report.

Press releases published on July 16, 2025

Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch

Tevogen.AI Targets Faster Time-to-Market with AI-Powered Patient Matching Following PredicTcell™ Alpha Launch

Advanced algorithms aim to reduce trial planning timelines, accelerating time-to-market for new therapies Initiative to support Tevogen Bio’s ExacTcell™ pipeline with a goal of enhancing commercial viability and shareholder value WARREN, N.J., July 16, …

eMI Aesthetics Announces Launch of AI-Powered Aesthetic Simulation Platform for Cosmetic Treatment Visualization

eMI Aesthetics Announces Launch of AI-Powered Aesthetic Simulation Platform for Cosmetic Treatment Visualization

Miami, FL, July 16, 2025 (GLOBE NEWSWIRE) -- eMI Aesthetics, a leader in AI-driven cosmetic imaging, today announced the launch of its AI-powered aesthetic simulation platform for cosmetic treatment visualization. With over 100,000 users, eMI Aesthetics' …

Aesthetic Business Strategist Dr. Kalpana Sundar to Host Transformational Profit Accelerator Bootcamp for Medspa Owners in Albuquerque – August 7–10, 2025

Aesthetic Business Strategist Dr. Kalpana Sundar to Host Transformational Profit Accelerator Bootcamp for Medspa Owners in Albuquerque – August 7–10, 2025

ALBUQUERQUE, New Mexico, July 16, 2025 (GLOBE NEWSWIRE) -- As the medical aesthetics industry continues to experience exponential growth, many medspa owners and aesthetic providers find themselves overwhelmed — juggling clients, marketing, operations, and …

A Statement from the Global Virus Network (GVN) on the Rapidly Escalating Measles Crisis in the U.S. and Worldwide

A Statement from the Global Virus Network (GVN) on the Rapidly Escalating Measles Crisis in the U.S. and Worldwide

TAMPA, Fla., July 16, 2025 (GLOBE NEWSWIRE) -- The Global Virus Network (GVN), a coalition of leading human and animal virologists from 80+ Centers of Excellence and Affiliates in more than 40 countries, is sounding the alarm over a sharp resurgence of …

Dallas Business Journal Recognizes U.S. Oral Surgery Management for Continued Growth

Dallas Business Journal Recognizes U.S. Oral Surgery Management for Continued Growth

IRVING, Texas, July 16, 2025 (GLOBE NEWSWIRE) -- For the second year in a row, the Dallas Business Journal has named Irving’s U.S. Oral Surgery Management (USOSM) to this year’s Fast 50 – a list of the 50 fastest growing companies in the Dallas-Fort Worth …

Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions

Windtree To Launch BNB Crypto Treasury Strategy With Agreement For $60 Million Investment Led By Build And Build Corp. With Up To $140 Million More In Follow On Subscriptions

WARRINGTON, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT) is excited to announce it has entered into a $60 million securities purchase agreement led by Build and Build Corp, with the …

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

OKYO Pharma Unveils Strong Phase 2 Clinical Trial Results for Urcosimod to Treat Neuropathic Corneal Pain

After 12 weeks of treatment, 75% of per-protocol patients receiving 0.05% urcosimod showed greater than 80% reduction in neuropathic corneal pain (NCP), as measured by Visual Analogue Scale (VAS), demonstrating highly effective treatment. Urcosimod (0.05%) …

Intuitive demonstrates telesurgery capabilities

Intuitive demonstrates telesurgery capabilities

SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, has today demonstrated its telesurgery capabilities by remotely connecting two …

Gain Therapeutics Announces Pricing of $7.0 Million Public Offering

Gain Therapeutics Announces Pricing of $7.0 Million Public Offering

BETHESDA, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, …

Lattimore Physical Therapy & Sports Rehabilitation Network Rolls Out Athelas Air to 35 Locations

Lattimore Physical Therapy & Sports Rehabilitation Network Rolls Out Athelas Air to 35 Locations

MOUNTAIN VIEW, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Athelas, healthcare technology company powered by Commure, today announced the successful deployment of its unified EHR platform, Athelas Air, at Lattimore Physical Therapy …

Ensemble Announces Strategic Revenue Cycle Partnership with Methodist Le Bonheur Healthcare

Ensemble Announces Strategic Revenue Cycle Partnership with Methodist Le Bonheur Healthcare

CINCINNATI, Ohio, July 16, 2025 (GLOBE NEWSWIRE) -- Ensemble, the nation’s leading revenue cycle managed services partner for healthcare organizations, announced today that Methodist Le Bonheur Healthcare (MLH) has selected it as its strategic revenue …

Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos

Following Psychedelic Science 2025 Success, MAPS Publishes First of Hundreds of Conference Session Videos

Enhanced Virtual Trip platform goes live with improved user experience and first selection of PS2025 session videos Conference drew 8,000+ attendees, more than $1 million donated, and 1,100+ recurring donors joined the new membership program MAPS …

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

CYCLACEL PHARMACEUTICALS COMMENTS ON RECENT STOCK PRICE VOLATILITY

Kuala Lumpur, Malaysia, July 16, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”), a biopharmaceutical company developing innovative medicines, today commented on recent stock price …

DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC

DIAGNOS Files FDA Pre-Submission for its CARA System: Strategic Entry into the U.S. Optometry Market with Support from ORA LLC

BROSSARD, Quebec, July 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the early detection of retinal and systemic diseases, is …

DIAGNOS dépose une pré-soumission auprès de la FDA pour son système CARA : Entrée stratégique sur le marché américain de l'optométrie avec le soutien d'ORA LLC

DIAGNOS dépose une pré-soumission auprès de la FDA pour son système CARA : Entrée stratégique sur le marché américain de l'optométrie avec le soutien d'ORA LLC

BROSSARD, Québec, 16 juill. 2025 (GLOBE NEWSWIRE) -- Diagnos inc. (« DIAGNOS » ou la « Société ») (Bourse de croissance TSX : ADK, OTCQB : DGNOF, FWB : 4D4A), un leader canadien de l'intelligence artificielle (IA) pour la détection précoce des maladies …

BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience

BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience

LAS VEGAS, July 16, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), an innovator in evidence-based wellness solutions, today announced the upcoming national release of NeuroRush™, a next-generation nootropic designed to support sustained cognitive …

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15

SARASOTA, FL, July 16, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced completion of dosing in a U …

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

SeaStar Medical Grows Customer Base and Expands QUELIMMUNE Surveillance Registry

Highest Rated Children’s Medical Centers Now Employ QUELIMMUNE for Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance DENVER, July 16, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical …

Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction

Henry Ford Health Initiates Patient Enrollment for BioCardia’s CardiAMP HF II Pivotal Study for Ischemic Heart Failure of Reduced Ejection Fraction

SUNNYVALE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announced today that Henry Ford Health in Detroit, …

Silexion Therapeutics Announces 1-for-15 Reverse Share Split

Silexion Therapeutics Announces 1-for-15 Reverse Share Split

Grand Cayman, Cayman Islands, July 16, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service